Simple Summary Many older adults with acute myeloid leukemia (AML) cannot receive intensive treatment because of comorbidities or frailty. Newer, lower-intensity treatments have expanded options for these patients. In this retrospective analysis, we examined treatment patterns, survival, and healthcare utilization in p...
Tina Y. Zhang, Alex Y. Ge, Shyam A. Patel et al.· Cancers· 0 citations
The mechanisms underlying primary and secondary refractoriness to conventional single-targeting CAR-T therapies for B cell lymphomas are discussed and the ongoing challenges with existing CAR constructs are explored.
Toshali Pandey, D. Samat, Saurabh Dahiya et al.· Frontiers in Immunology· 1 citation
Looking ahead, menin inhibitors may increasingly be incorporated into earlier lines of therapy, used as maintenance following allogeneic stem cell transplantation, and integrated into treatment approaches guided by measurable residual disease and evolving patterns of drug resistance.
Tina Y. Zhang, Shyam A. Patel, Talha Badar· Cancers· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.